Pathfinder Cell Therapy, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Richard L. Franklin
IPO Date
2000-01-03
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.00M
| -5.2 |
| 31 Dec 2012 | FY | 56.1% | -1975.4% | 79.0% | -632.6% | -0.55 | 0.05 | -5.9 |
| 31 Dec 2011 | FY | 64.4% | -25920.5% | 2676.4% | -2938.2% | -0.45 | 0.37 | -1.4 |
| 31 Dec 2010 | FY | 73.3% | -603.5% | 213.4% | -1431.7% | -0.47 | 0.13 | -44.1 |
| 31 Dec 2009 | FY | 54.4% | -1139.7% | -487.3% | -336.0% | 0.01 | 3.15 | -4.9 |
| 31 Dec 2008 | FY | 43.6% | -2433.1% | -151.7% | -132.2% | 0.00 | 7.61 | -2.3 |
| 31 Dec 2007 | FY | 78.4% | -3450.0% | -164.2% | -137.1% | 0.00 | 5.79 | -10.1 |
| 31 Dec 2006 | FY | 85.2% | -2743.0% | -117.1% | -93.2% | 0.02 | 4.61 | -17.0 |
| 31 Dec 2005 | FY | 0.0% | 0.0% | -1603.0% | -197.1% | 0.30 | 0.94 | -12.4 |
| -2.4 |
| 31 Mar 2015 | Q1 | 0.0% | 0.0% | 5.6% | -404.7% | -0.83 | 0.01 | -1.8 |
| 31 Dec 2014 | Q4 | 0.0% | 0.0% | 6.2% | -347.2% | -0.84 | 0.01 | -0.4 |
| 30 Sept 2014 | Q3 | 0.0% | 0.0% | 6.3% | -507.1% | -0.85 | 0.01 | -1.2 |
| 30 Jun 2014 | Q2 | 0.0% | 0.0% | 6.2% | -454.8% | -0.85 | 0.01 | -2.3 |
| 31 Mar 2014 | Q1 | 0.0% | 0.0% | 9.6% | -341.5% | -0.85 | 0.02 | -3.8 |
| 31 Dec 2013 | Q4 | 0.0% | 0.0% | 10.2% | -298.1% | -0.88 | 0.03 | -5.1 |
| 30 Sept 2013 | Q3 | 50.0% | -4650.0% | 9.1% | -178.8% | -0.46 | 0.04 | -1.8 |
| 30 Jun 2013 | Q2 | 55.6% | -1611.1% | 7.8% | -180.1% | -0.49 | 0.03 | -8.6 |